Acesulfame K
GI(Glucose = 100)
Primary · 0 GI
High-intensity sweeteners — no available carbohydrate for classical GI (2020)
Energy(kcal/100g)
Primary · 0 kcal/100g
High-intensity sweeteners — no available carbohydrate for classical GI (2020)
Carbs(g/100g)
Primary · 0 g/100g
High-intensity sweeteners — no available carbohydrate for classical GI (2020)
Sugars(g/100g)
Primary · 0 g/100g
High-intensity sweeteners — no available carbohydrate for classical GI (2020)
Functional benefits
No cited minerals or other functional notes on file yet.
Cited minerals can add up to +2 on Best sweetener for everyday health — see Methods.
Risks & side effects
High-intensity sweetener
note
Use-level and blends matter. Packet fillers are different products. Regulatory class note — not scored.
FDA — High-intensity sweeteners permitted for use in food (2023)
WHO: not for weight control
caution
WHO 2023, conditional (low certainty): not for weight control or lowering disease risk — no long-term body-fat benefit. Not a safety ruling. Scored: the energy points it earns over sucrose are taken back on Everyday Health, Weight goals and Easy on the liver; not on Diabetic-friendly (WHO excludes people with diabetes).
WHO — Use of non-sugar sweeteners: WHO guideline (2023)
Coronary heart disease link (cohort)
note
BMJ 2022 NutriNet-Santé (103,388 adults): HR 1.40 (1.06–1.84). Observational association, not proof of cause. Scored: CV signal −7 on Everyday Health and Weight goals (synthetics are not on Diabetic-friendly; not on Easy on the liver), once per sweetener however many links.
Debras et al. — Artificial sweeteners and risk of cardiovascular diseases: NutriNet-Santé cohort (BMJ) (2022)
Cancer link (cohort)
note
PLOS Medicine 2022 NutriNet-Santé (102,865 adults): overall cancer HR 1.13 (1.01–1.26) for higher consumers vs non-consumers. Observational association, not proof of cause; no IARC or JECFA cancer finding for acesulfame K. Scored: cancer signal −7 on every list, Easy on the liver included (synthetics are not on Diabetic-friendly).
Debras et al. — Artificial sweeteners and cancer risk: NutriNet-Santé cohort (PLOS Medicine) (2022)
Not medical advice. Published recipe penalties (if any) are on Methods — not a clinical severity scale.
Notes
No extra context notes on file yet.
Notes explain what the open axis or risk labels alone can miss — not medical advice.
An empty cell means we do not yet have a method-cited source. Rank 1 wins the published rule; it is not medical advice.